ETFs
A
AUPH
Aurinia Pharmace
15.35
+0.11+0.72%After Hours: 15.45 +0.10 +0.65%19:34 07/24 EDT
OPEN/PREV CLOSE15.41/15.24
TODAY RANGE15.13-15.52
VOL792.97K
MARKET CAP1.97B
52 WEEK RANGE8.55-19.25
AVG VOL (3M)1.48M
% TURNOVER0.62%
TURNOVER--
P/E (TTM)7.09
% RANGE2.56%
EPS(TTM)2.166
P/E(FORWARD)15.66
P/B3.536
BVPS4.341
DIVIDEND--
P/S7.18
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.83B
SHARES OUTSTANDING128.60M
NEXT EARNINGS07/29-08/03
FREE FLOAT118.92M
LOT SIZE1
EX-DATE10/23/2013
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Playing The Biotech Breakout With Insiders
Seeking Alpha·3d ago
The Credit Cycle Is Flashing Yellow
TipRanks·07/06 19:35
TD Cowen Reaffirms Their Buy Rating on Aurinia Pharmaceuticals (AUPH)
TipRanks·07/06 12:16
Aurinia Pharmaceuticals announces initiation of PRESERVE study
PUBT·07/06 12:01
Aurinia Pharmaceuticals announces press release availability
NASDAQ·06/26 08:59
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
NASDAQ·06/25 12:40
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
NASDAQ·06/23 11:08
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Barron‘s·06/12 22:47
13D Filings
TipRanks·06/12 16:34
Aurinia’s PRESERVE Trial: New Combination Strategy for Lupus Nephritis in Focus
TipRanks·06/04 21:48
Aurinia Shareholders Back Board Slate and Governance Measures
Same Industry
Name/Symbol
Change%
Price